Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department

NCT02492295 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.

NCT NCT02492295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02492295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department
Lead sponsor
Albert Einstein Healthcare Network
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2014
Completion date
January 1, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache